Catherine Ann Ball

Title: The Innovative Contributions of Catherine Ann Ball

Introduction

Catherine Ann Ball is a prominent inventor based in Mountain View, CA, known for her significant contributions to genomic research and health outcome prediction. With a total of 10 patents to her name, she has made remarkable strides in the field of genetics and health analytics.

Latest Patents

Catherine's latest patents include groundbreaking work on haplotype phasing models. These novel haplotype cluster Markov models are designed to phase genomic samples rapidly and accurately without the need to rebuild the models for new samples. The models set transition probabilities to ensure that the probability of any allele appearing within any haplotype is non-zero. Additionally, unlikely pairs of haplotypes are discarded at each level until a specified likelihood mass is eliminated. The models also allow for the merging of nodes during the building process to consolidate haplotype clusters with similar distributions. Another significant patent focuses on predicting health outcomes. This method identifies the likelihood of developing medical conditions using health histories from genetically related individuals. It involves analyzing genetic data and health histories to generate a health outcome score, which measures the risk of developing specific health issues.

Career Highlights

Catherine has worked with notable companies such as Ancestry.com DNA, LLC and AncestryHealth.com, LLC. Her work in these organizations has been pivotal in advancing genetic research and health analytics.

Collaborations

Catherine has collaborated with esteemed colleagues, including Kenneth Gregory Chahine and Mathew J Barber, contributing to her innovative projects and research.

Conclusion

Catherine Ann Ball's contributions to the fields of genomics and health prediction exemplify her role as a leading inventor. Her innovative patents and collaborations continue to influence the landscape of genetic research and health outcomes.